Knowledge Base/Herbs/Ephedra Root
Educational and cultural reference only — not medical advice. We do not diagnose, do not prescribe, do not recommend medicines or doses, and make no claim to treat or cure any condition. Nothing here should delay you from seeking care. If you have a health concern, consult a licensed healthcare professional.
收涩药(止汗)· 麻黄属植物根部 · Astringent drug (arresting sweating); the root of an Ephedra species

Ephedra Root má huáng gēn · 麻黄根

Radix Ephedrae — the dried root and rhizome of Ephedra sinica Stapf, E. intermedia Schrenk et C.A.Mey. or E. equisetina Bunge (family Ephedraceae). Not the stem: the stem is a different drug (麻黄) with the opposite traditional direction.

Nature and flavour. Sweet and astringent, neutral. Heart and Lung systems.

A teaching example of how much the part of the plant matters. The stem of Ephedra is the classical diaphoretic that drives sweating outward; the root is the classical drug for arresting it. The sources record the root for spontaneous sweating, for night sweating, and for the sweating of deficiency states, and this opposition — one plant, two directions — is repeated across the classical texts. Modern phytochemistry supports the direction of the distinction in a general way: the root carries a different alkaloid profile and a lower total alkaloid content than the aerial stem. That is a relative statement about chemistry, not a statement that the root is inert, and it should not be read as a safety guarantee.

性味归经。甘、涩,平。归心、肺经。

说明「药用部位差多少」的教科书式例子。麻黄的茎是古典发汗药,把汗往外推;麻黄的根是古典止汗药。文献记载其根用于自汗、盗汗与虚证之汗,这种「同一株植物、两个方向」的对举在古典文本里反复出现。现代植物化学大体支持这种区分的方向:根部所含生物碱谱与地上茎不同,总生物碱含量也较低。这是关于化学组成的相对陈述,不等于说根是惰性的,更不能当作安全保证来读。

Classical category · no formulas, no dosages, no herb-drug combinations are given.
Safety. The genus Ephedra is legally controlled in many jurisdictions and that is the first thing to say. Ephedrine and the other Ephedra alkaloids are regulated: in the United States the FDA ended the sale of ephedrine-alkaloid dietary supplements in 2004, Ephedra raw material remains a DEA-regulated and FDA-restricted commodity, and in China Ephedra plant material and ephedrine-type preparations fall under precursor-control rules. Cross-border movement of Ephedra material is therefore not a casual matter. Anyone with hypertension, heart disease or arrhythmia, hyperthyroidism, glaucoma, prostatic enlargement with hesitancy, or insomnia should not take Ephedra material in any form, root included; the interaction risks with MAOIs, stimulants, decongestants, caffeine and antihypertensive medicines are real. It must never be written up or sold as a stimulant or as a weight-loss aid — that use is what produced the case reports of stroke, myocardial infarction and sudden death, and it is not a traditional use. In pregnancy and breastfeeding, and in children, it is not advisable.

麻黄属在全球多地受法律管制,这是首先要写的话。麻黄碱与其它麻黄属生物碱属于受管制物质:美国 FDA 于 2004 年终止麻黄碱类膳食补充剂的销售,麻黄属原材料仍属 DEA 管制与 FDA 限制的商品;在中国,麻黄属植物材料与麻黄碱类制剂同样纳入易制毒化学品管理。因此跨境携带麻黄属材料不是小事。高血压、心脏病或心律失常、甲状腺功能亢进、青光眼、前列腺肥大伴排尿犹豫、失眠者,不应服用任何形式的麻黄属材料,根也包括在内;与单胺氧化酶抑制剂、兴奋剂、减充血剂、咖啡因及降压药的相互作用风险是真实的。绝不可把它写成或当作兴奋剂、减重用品来卖——那正是导致脑卒中、心肌梗死与猝死个案报告的用途,且并非传统用法。孕期、哺乳期与儿童不宜。

← All Herbs entries